Spots Global Cancer Trial Database for pancreas cancer
Every month we try and update this database with for pancreas cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy | NCT04774198 | Pancreas Cancer | blood sample | 18 Years - | Rigshospitalet, Denmark | |
| The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy | NCT06282809 | Pancreas Cancer Adenocarcinoma ... Pancreatic Canc... Tumor of Pancre... | HistoSonics Edi... | 18 Years - | HistoSonics, Inc. | |
| Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry. | NCT04937322 | Bile Duct Cance... Pancreas Cancer | Interventional ... | 18 Years - | Methodist Health System | |
| Supportive Oncology Care at Home for Patients With Pancreatic Cancer Receiving Preoperative FOLFIRINOX | NCT03798769 | Pancreas Cancer | Supportive Onco... | 18 Years - | Massachusetts General Hospital | |
| A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors | NCT06440005 | Cancer Advanced Cancer Locally Advance... Metastatic Soli... Triple Negative... Pancreas Cancer Pancreatic Aden... | AGX101 | 18 Years - | Angiex, Inc. | |
| GPC3/Mesothelin-CAR-γδT Cells Against Cancers | NCT06196294 | Pancreas Cancer Lung Cancer Liver Cancer Mesothelioma CAR-T Cell Ther... Solid Tumor, Ad... | Cell therapy fo... | 18 Years - 75 Years | Second Affiliated Hospital of Guangzhou Medical University | |
| Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy | NCT04466189 | Pancreas Cancer | 19 Years - | National Cancer Center, Korea | ||
| MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial | NCT05975593 | Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Cervical Cancer Pancreas Cancer Pancreatic Canc... Cancer of the C... Cancer of the P... | 18 Years - | Washington University School of Medicine | ||
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors | NCT06010862 | Gastric Cancer Colon Cancer Pancreas Cancer Esophagus Cance... Cholangiocarcin... Lung Cancer Breast Cancer | CEA CAR-T cells CEA CAR-T cells | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer | NCT05191498 | Pancreas Cancer | QuiremSpheres® | 18 Years - | Radboud University Medical Center | |
| An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy | NCT04739046 | Pancreas Cancer | Theragene arm | 19 Years - 75 Years | Seoul National University Bundang Hospital | |
| Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors | NCT06065059 | Breast Cancer Ovarian Cancer Pancreas Cancer Prostate Cancer BRCA1 Mutation BRCA-Mutated Ov... BRCA-Associated... HRD Positive Ad... | TNG348 Olaparib | 18 Years - | Tango Therapeutics, Inc. | |
| Clinical Trial for Advanced or Metastatic Pancreatic Cancer | NCT06255912 | Pancreas Cancer | LTC004 + MIL-97 LTC004 + MIL-97... | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Pancreas Cancer Surveillance Using an Abbreviated MRI | NCT04592393 | Pancreas Cancer | Abbreviated PB ... Gene mutation t... Conventional fo... | 50 Years - 75 Years | Seoul National University Hospital | |
| An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy | NCT04739046 | Pancreas Cancer | Theragene arm | 19 Years - 75 Years | Seoul National University Bundang Hospital | |
| Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma | NCT04331041 | Pancreas Cancer Cancer of the P... Pancreas Adenoc... | Adaptive stereo... Defactinib Tumor biopsy Research blood ... | 18 Years - | Washington University School of Medicine | |
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas | NCT01231347 | Adenocarcinoma ... Advanced Solid ... Cancer Cancer of Pancr... Cancer of the P... Metastases Metastatic Canc... Metastatic Panc... Pancreas Cancer Pancreatic Canc... Bone Metastases Endocrine Cance... Oncology Oncology Patien... Solid Tumors Advanced Malign... | AMG 479 Placebo AMG 479 gemcitabine | 18 Years - | NantCell, Inc. | |
| Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer | NCT01411072 | Pancreas Cancer | gemcitabine 5-fluorouracil | 18 Years - | AHS Cancer Control Alberta | |
| Impact of Pancreatic Endoscopic Drainage on Exocrine Pancreatic Function in Unresectable Pancreatic Cancer | NCT05244174 | Pancreatic Neop... Pancreatic Exoc... | Pancreatic sten... | 18 Years - | Hospital Clinico Universitario de Santiago | |
| Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC | NCT04140526 | Non Small Cell ... Advanced Solid ... Metastatic Mela... Metastatic Head... Metastatic Rena... Metastatic Colo... Sarcomas Metastatic Pros... Ovarian Cancer Small Cell Lung... Metastatic Brea... Pancreas Cancer Gastric Cancer Esophageal Canc... Gastroesophagea... Cervical Cancer Adenoid Cystic ... Salivary Gland ... Urothelial Carc... | ONC-392 Pembrolizumab Docetaxel | 18 Years - | OncoC4, Inc. | |
| A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors | NCT02999672 | Bladder Cancer Pancreas Cancer Cholangiocellul... | Trastuzumab Emt... | 18 Years - | Hoffmann-La Roche | |
| Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | NCT01446458 | Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreas Neopla... | Modified FOLFIR... Stereotactic Bo... | 21 Years - | Emory University | |
| Registry Study - Whipple at the Splenic Artery | NCT01155882 | Pancreas Cancer | Whipple at the ... | 18 Years - 85 Years | Washington University School of Medicine | |
| BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer | NCT02608229 | Pancreatic Canc... Cancer of Pancr... Cancer of the P... Pancreas Cancer | BVD-523 Nab-paclitaxel Gemcitabine Tumor biopsy | 18 Years - | Washington University School of Medicine | |
| Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion | NCT05245500 | Mesothelioma Non Small Cell ... Malignant Perip... Solid Tumor Pancreatic Aden... Advanced Solid ... | MRTX1719 | 18 Years - | Mirati Therapeutics Inc. | |
| Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer | NCT01016639 | Stomach Cancer Gall Bladder Ca... Bile Ductus Can... Pancreas Cancer Colorectal Canc... | oxaliplatin, ca... | 18 Years - | Lund University Hospital | |
| Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer | NCT01915225 | Colorectal Neop... Gastric Neoplas... Cholangiocarcin... Bile Duct Cance... Pancreas Cancer | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors | NCT06006390 | Gastric Cancer Colon Cancer Rectal Cancer Esophageal Canc... Pancreas Cancer Lung Cancer Breast Cancer | CEA-targeted CA... CEA-targeted CA... | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| Choices About Genetic Testing And Learning Your Risk With Smart Technology | NCT06184867 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... Breast Cancer Pancreas Cancer Colorectal Canc... Endometrial Can... Prostate Cancer | Relational Agen... Clinical Letter | 18 Years - | Rutgers, The State University of New Jersey | |
| Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs | NCT04687410 | Pancreas Neopla... Pancreas Cancer | ProControl, Med... TopGain, Medi-G... | 18 Years - | Herlev Hospital | |
| Cross-sectional Follow-up on Digestive and Social Functions of SPN | NCT05604716 | Solid Pseudopap... Pancreas Cancer | observational s... | - | Peking Union Medical College Hospital | |
| Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer | NCT00375310 | Pancreatic Canc... Adenocarcinoma ... | Gemcitabine, So... Radiotherapy | 18 Years - | Indiana University | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03697239 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | University of California, San Diego | |
| Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors | NCT05704985 | Cancer Solid Tumor Colorectal Canc... Pancreas Cancer Non Small Cell ... Head and Neck C... Gynecologic Can... Skin Cancer Kidney Cancer | DK210 (EGFR) Radiation thera... Immune checkpoi... Chemotherapy | 18 Years - | DEKA Biosciences | |
| Conventional Versus Elastography Targeted Endoscopic Ultrasound Fine Needle Aspiration of Solid Pancreatic Lesions | NCT03210948 | Pancreas Cancer | RTE-guided EUS-... Conventional EU... | 18 Years - | Ospedali Riuniti di Foggia | |
| Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations | NCT06229340 | RAS Mutation Ras (Kras or Nr... Colorectal Canc... Pancreas Cancer Lung Cancer Melanoma Refractory Canc... | Leflunomide The combination... | 18 Years - 85 Years | N.N. Petrov National Medical Research Center of Oncology | |
| Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy | NCT04106167 | Advanced Solid ... Lymphoma Gastric Cancer Colorectal Canc... Head and Neck C... Squamous Cell C... EGFR Positive S... HER2-positive B... Hepatocellular ... Small-cell Lung... Renal Cell Carc... Pancreas Cancer Melanoma NSCLC Urothelial Carc... Cervical Cancer Microsatellite ... Merkel Cell Car... | Allogeneic natu... | 18 Years - | Fate Therapeutics | |
| Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer | NCT00487851 | Pancreatic Neop... Biliary Tract N... Duodenal Neopla... | surgery endoscopic stra... | - | Karolinska Institutet | |
| The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer | NCT03637569 | Pancreas Cancer Cholangiocarcin... Gallbladder Can... | Measurement of ... | 18 Years - | Samsung Medical Center | |
| Preoperative Stent Study | NCT00501176 | Pancreas Cancer | Plastic and met... | 20 Years - | Karolinska Institutet | |
| Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail | NCT00500968 | Pancreas Cancer Fistula | stent Distal pancreat... | 20 Years - | Karolinska Institutet | |
| Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE) | NCT06277531 | Biliary Strictu... Bile Duct Cance... Pancreas Cancer | 18 Years - 85 Years | Peking University Third Hospital | ||
| Azacitidine and Pembrolizumab in Pancreatic Cancer | NCT03264404 | Pancreas Cancer | Pembrolizumab Azacitidine | 18 Years - | Columbia University | |
| Promoting CT Engagement for Pancreatic Cancer With App | NCT06252545 | Pancreas Cancer | semistructured ... feedback | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer. | NCT05497778 | Pancreas Cancer | Gemcitabine Nab paclitaxel IM156 | 18 Years - | M.D. Anderson Cancer Center | |
| Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors | NCT04889742 | Recurrent Cance... Prostate Cancer Cervical Cancer Anal Cancer Sarcoma Rectal Cancer Neuroendocrine ... Esophageal Canc... Pancreas Cancer Squamous Cell C... | loco-regional h... | 18 Years - | Charite University, Berlin, Germany | |
| A Study of MGC026 in Participants With Advanced Solid Tumors | NCT06242470 | Advanced Solid ... Advanced Cancer Metastatic Canc... Squamous Cell C... Non Small Cell ... Small-cell Lung... Bladder Cancer Sarcoma Endometrial Can... Melanoma Castration Resi... Cervical Cancer Colorectal Canc... Gastric Cancer Gastro-esophage... Pancreas Cancer Clear Cell Rena... Hepatocellular ... Platinum-resist... | MGC026 Dose Esc... MGC026 Dose for... | 18 Years - | MacroGenics | |
| The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer Patients | NCT04528745 | Pancreas Cancer Colorectal Canc... | Bio Impedance S... | 18 Years - | University of Copenhagen | |
| A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma | NCT05997147 | Predictive Canc... Pancreas Cancer | 18 Years - 80 Years | Tianjin Medical University Cancer Institute and Hospital | ||
| International CAPS Registry: Pancreas Cancer Cases in Surveillance Programs | NCT02703545 | Pancreas Cancer | 18 Years - | Johns Hopkins University | ||
| CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases | NCT02416466 | Liver Metastase... | anti-CEA CAR-T ... Sir-Spheres | 18 Years - | Roger Williams Medical Center | |
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) | NCT02707328 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine nab-paclitaxel CyberKnife | 18 Years - | The Cooper Health System | |
| Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence | NCT06228599 | Pancreas Cancer | Treatment Plan | 18 Years - | Medical College of Wisconsin | |
| Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer | NCT05218889 | Pancreatic Canc... PDAC - Pancreat... Pancreas Cancer Pancreatic Neop... | surufatinib + c... nab-paclitaxel ... | 18 Years - 75 Years | Chinese PLA General Hospital | |
| Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) | NCT03410030 | Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreas Metast... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | HonorHealth Research Institute | |
| Improvement of Care of Patients Undergoing Pancreaticoduodenectomy | NCT04668781 | Pancreatic Dise... Pancreas Cancer | Analgesia via e... Analgesia via w... | 18 Years - 90 Years | Helsinki University Central Hospital | |
| Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results | NCT05226572 | Pancreatic Aden... Pancreas Cancer Pancreas Metast... | endoscopic ultr... | 18 Years - 90 Years | University of Bologna | |
| A Study of MGC026 in Participants With Advanced Solid Tumors | NCT06242470 | Advanced Solid ... Advanced Cancer Metastatic Canc... Squamous Cell C... Non Small Cell ... Small-cell Lung... Bladder Cancer Sarcoma Endometrial Can... Melanoma Castration Resi... Cervical Cancer Colorectal Canc... Gastric Cancer Gastro-esophage... Pancreas Cancer Clear Cell Rena... Hepatocellular ... Platinum-resist... | MGC026 Dose Esc... MGC026 Dose for... | 18 Years - | MacroGenics | |
| Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy | NCT06135649 | Pancreas Cancer Pancreatic Aden... | Systematic lymp... | - | Universita di Verona | |
| Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model | NCT03934606 | Pancreas Cancer Prostate Cancer Hereditary Canc... Genetic Predisp... | Genetic testing... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma | NCT04923529 | Pancreas Cancer | TAS 102 | 18 Years - 75 Years | The University of Hong Kong | |
| Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer | NCT06026943 | Pancreatic Canc... Unresectable Pa... Pancreatic Aden... | DaRT seeds inse... | 18 Years - 120 Years | Alpha Tau Medical LTD. | |
| Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE) | NCT02312167 | Cancer of Diges... Ovarian Cancer | confocal laser ... | 18 Years - | Institut Mutualiste Montsouris | |
| Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer | NCT04137822 | Pancreas Cancer Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... | IMM-101 | 18 Years - | Impatients N.V. trading as myTomorrows | |
| Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors | NCT04640480 | Colorectal Canc... Breast Cancer Pancreas Cancer Ovarian Cancer Small-cell Lung... Gastric Cancer Head and Neck C... | SNB-101 | 19 Years - | SN BioScience | |
| Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer | NCT01394120 | Carcinoma, Panc... | Targeted Therap... Standard Chemot... | 18 Years - | Grupo Hospital de Madrid | |
| EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. | NCT06263088 | Gastrointestina... Colon Cancer Rectal Cancer Anal Cancer Esophageal Canc... Stomach Cancer Appendix Cancer Pancreas Cancer Liver Cancer Neuroendocrine ... | EQUITY GI | 18 Years - | Case Comprehensive Cancer Center | |
| CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC) | NCT03682744 | Peritoneal Carc... Peritoneal Meta... Colorectal Canc... Gastric Cancer Breast Cancer Pancreas Cancer Carcinoembryoni... | anti-CEA CAR-T ... | 18 Years - | Sorrento Therapeutics, Inc. | |
| Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver | NCT05610826 | Pancreatic Neur... Pancreas Cancer | cytoreductive s... Lutathera - a s... Peptide recepto... | 18 Years - | University of Chicago | |
| Milademetan in Advanced/Metastatic Solid Tumors | NCT05012397 | Solid Tumors Head and Neck C... Cholangiocarcin... Sarcoma Lung Adenocarci... Bladder Urothel... Stomach Adenoca... Breast Cancer I... Ovarian Carcino... Cervical Cancer Non Small Cell ... Gastric Cancer Biliary Tract C... Melanoma Pancreas Cancer MDM2 Gene Ampli... Testicular Germ... Adrenocortical ... | RAIN-32 | 18 Years - | Rain Oncology Inc | |
| The Cancer of the Pancreas Screening-5 CAPS5)Study | NCT02000089 | Pancreas Cancer Peutz-Jeghers S... Gene Mutation Germline Mutati... Lynch Syndrome | Secretin MRI Tumor marker ge... | 18 Years - | Johns Hopkins University | |
| RFA for Malignant Biliary Obstruction | NCT03166436 | Cholangiocarcin... Pancreas Cancer | Radiofrequency ... Biliary stentin... | 18 Years - | Institute for Clinical and Experimental Medicine | |
| The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas) | NCT06276764 | IPMN, Pancreati... Pancreas Cancer Pancreatic Cyst | LINFU® Standard imagin... | 18 Years - 90 Years | Adenocyte, LLC | |
| Pancreatic Cancer Early Detection Consortium | NCT04970056 | Pancreas Cancer Pancreas Cyst Pancreatic Duct... Genetic Predisp... | 18 Years - 90 Years | Arbor Research Collaborative for Health | ||
| Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine") | NCT01726582 | Pancreatic Aden... | Milestone 1: Ta... Milestone 2: Ch... Milestone 3: Ta... Milestone 3: Ch... Milestone 4: st... Milestone 4: Ch... Milestone 5: Ta... Milestone 5: Ch... Milestone 6: Ge... Milestone 6: Ch... Milestone 7: Ch... Milestone 8: Ta... Milestone 9: Ge... Milestone 10: N... | 18 Years - | Medical College of Wisconsin | |
| Radiofrequency Ablation for Biliopancreatic Malignancy | NCT02468076 | Pancreas Cancer Cholangiocarcin... Obstructive Jau... | Radiofrequency ... | 18 Years - | Universitaire Ziekenhuizen KU Leuven | |
| Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions | NCT04324294 | Pancreatitis Pancreas Cancer Pancreas Cyst | EUS enhanced wi... | 18 Years - | Cedars-Sinai Medical Center | |
| Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors | NCT04429542 | Head and Neck S... Squamous Cell C... Colorectal Canc... Squamous Cell C... EGFR Amplificat... Epithelial Ovar... Pancreas Cancer Cutaneous Squam... Head and Neck N... Carcinoma, Squa... Squamous Cell C... | BCA101 Pembrolizumab | 18 Years - | Bicara Therapeutics | |
| A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer | NCT01042028 | Pancreatic Canc... | Everolimus, Cet... Capecitabine, O... | 18 Years - | Odense University Hospital | |
| Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer | NCT03260842 | Pancreatic Cyst Pancreas Diseas... | Bio-Specimen Co... | 18 Years - | Stanford University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
